Thao T Doan

Thao T Doan serves as an Adjunct Lecturer in the Department of Pharmacology at Northwestern University's Feinberg School of Medicine, with her current appointment confirmed through 2024 disclosures.

Her research integrates pharmacogenomics with clinical pharmacology, focusing on drug metabolism mechanisms and therapeutic optimization for inflammatory conditions. Key investigations include genetic determinants of drug transporters and biologic dosing strategies for gastrointestinal disorders, demonstrating translational expertise from molecular pathways to clinical trial design.

Publications reveal two primary research trajectories: the 2022 Gastroenterology paper establishes her work in optimizing adalimumab regimens for Crohn's disease through the SERENE CD trial, while the 2006 Clinical Pharmacology and Therapeutics study demonstrates foundational contributions to pharmacogenomic understanding of OATP1B1 transporters. Collectively, these works highlight expertise in bridging genetic variability with drug efficacy in both gastroenterology and systemic pharmacology contexts.